Clarithromycin-loaded liposomes offering high drug loading and less irritation

International Journal of Pharmaceutics

Volumn 443, Issue 1-2, 2013, Pages 318-327

  Liu, Xiaona ^a   Sun, Wei ^a   Zhang, Bo ^b   Tian, Bin ^c   Tang, Xing ^c   Qi, Na ^c   He, Haibing ^c   Li, Huifang ^c   Jin, Xiangqun ^a  

^a JILIN UNIVERSITY   (China)

^b LIAONING UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^c SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Clarithromycin; Less irritation; Lyophilization; Multilamellar liposomes; N hexanoic

Indexed keywords

CHOLESTEROL SULFATE; CLARITHROMYCIN; LIPOSOME; SUCROSE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AQUEOUS SOLUTION; ARTICLE; CONTROLLED STUDY; DRUG FORMULATION; DRUG STABILITY; DRUG STRUCTURE; DRUG SYNTHESIS; ENCAPSULATION; FREEZE DRYING; INFRARED SPECTROSCOPY; MOUSE; NONHUMAN; PARTICLE SIZE; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; RABBIT; ZETA POTENTIAL;

ANIMALS; ANTI-BACTERIAL AGENTS; CALORIMETRY, DIFFERENTIAL SCANNING; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CLARITHROMYCIN; CRYSTALLIZATION; DRUG COMPOUNDING; DRUG STABILITY; ERYTHROCYTES; FREEZE DRYING; HEMOLYSIS; INJECTIONS, INTRAVENOUS; LIPOSOMES; MICE; MICROSCOPY, ELECTRON, TRANSMISSION; MOLECULAR STRUCTURE; PAIN; PARTICLE SIZE; RABBITS; RATS; SKIN; SKIN IRRITANCY TESTS; SOLUBILITY; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; SURFACE PROPERTIES;

EID: 84873987531     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2013.01.023     Document Type: Article

References (29)

1. W. Abdelwahed, G. Degobert, S. Stainmesse, and H. Fessi Freeze-drying of nanoparticles: formulation, process and storage considerations Adv. Drug Deliv. Rev. 58 2006 1688 1713
2. J.B. Cannon, N. Adeyinka Williams, and K.J. Papp Reduction of pain on intravenous infusion with bile salt formulations for a macrolide antibiotic Int. J. Pharm. 114 1995 65 74
3. C.R. Comereski, P.D. Williams, C.L. Bregman, and G.H. Hottendorf Pain on injection and muscle irritation: a comparison of animal models for assessing parenteral antibiotics Fundam. Appl. Toxicol. 6 1986 335 338
4. T. Guan, Y. Miao, L. Xu, S. Yang, J. Wang, H. He, X. Tang, C. Cai, and H. Xu Injectable nimodipine-loaded nanoliposomes: preparation, lyophilization and characteristics Int. J. Pharm. 410 2011 180 187
5. T. Higuchi Mechanism of sustained-action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matrices J. Pharm. Sci. 52 1963 1145 1149
6. M.L. Immordino, F. Dosio, and L. Cattel Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential Int. J. Nanomed. 1 2006 297 315
7. J. Inoue, R. Ideue, D. Takahashi, M. Kubota, and Y. Kumazawa Liposomal glycosphingolipids activate natural killer T cell-mediated immune responses through the endosomal pathway J. Controlled Release 133 2009 18 23
8. F. Li, Y.J. Wang, Z.T. Liu, X. Lin, H.B. He, and X. Tang Formulation and characterization of bufadienolides-loaded nanostructured lipid carriers Drug Dev. Ind. Pharm. 36 2010 508 517
9. F. Li, Y. Weng, L.H. Wang, H.B. He, J.Y. Yang, and X. Tang The efficacy and safety of bufadienolides-loaded nanostructured lipid carriers Int. J. Pharm. 393 2010 203 211
10. H. Li, S.F. Nie, X.G. Yang, C.G. Wang, S.X. Cui, and W.S. Pan Optimization of tocol emulsions for the intravenous delivery of clarithromycin Int. J. Pharm. 356 2008 282 290
11. X. Liu, Y. Zhang, X. Tang, and H. Zhang Determination of entrapment efficiency and drug phase distribution of submicron emulsions loaded silybin J. Microencapsulation 26 2009 180 186
12. M.W. Lovell, H.W. Johnson, H.W. Hui, J.B. Cannon, P.K. Gupta, and C.C. Hsu Less-painful emulsion formulations for intravenous administration of clarithromycin Int. J. Pharm. 109 1994 45 57
13. R.A. Lovstad Fatty acid induced hemolysis. Protective action of ceruloplasmin, albumins, thiols and vitamin C Int. J. Biochem. 18 1986 771 775
14. Y. Lu, Y. Wang, and X. Tang Formulation and thermal sterile stability of a less painful intravenous clarithromycin emulsion containing vitamin E Int. J. Pharm. 346 2008 47 56
15. L.A. Meure, N.R. Foster, and F. Dehghani Conventional and dense gas techniques for the production of liposomes: a review AAPS 9 2008 798 809
16. K. Miyajima Role of saccharides for the freeze-thawing and freeze drying of liposome Adv. Drug Deliv. Rev. 24 1997 151 159
17. G. Mohammadi, A. Nokhodchi, M. Barzegar-Jalali, F. Lotfipour, K. Adibkia, N. Ehyaei, and H. Valizadeh Physicochemical and anti-bacterial performance characterization of clarithromycin nanoparticles as colloidal drug delivery system Colloids Surf. B 88 2011 39 44
18. Y. Nakagawa, S. Itai, T. Yoshida, and T. Nagai Physicochemical properties and stability in the acidic solution of a new macrolide antibiotic, clarithromycin, in comparison with erythromycin Chem. Pharm. Bull. 40 1992 725 728
19. C.O. Onyeji, C.H. Nightingale, D.P. Nicolau, and R. Quintiliani Efficacies of liposome-encapsulated clarithromycin and ofloxacin against Mycobacterium avium-M. intracellulare complex in human macrophages Antimicrob. Agents Chemother. 38 1994 523 527
20. I.I. Salem, and N. Duzgunes Efficacies of cyclodextrin-complexed and liposome-encapsulated clarithromycin against Mycobacterium avium complex infection in human macrophages Int. J. Pharm. 250 2003 403 414
21. A. Sharma, and U.S. Sharma Liposomes in drug delivery: progress and limitations Int. J. Pharm. 154 1997 123 140
22. B. Stark, G. Pabst, and R. Prassl Long-term stability of sterically stabilized liposomes by freezing and freeze-drying: effects of cryoprotectants on structure Eur. J. Pharm. Sci. 41 2010 546 555
23. L. Stuhne-Sekalec, N.Z. Stanacev, and S. Djokic Liposomes as carriers of macrolides: preferential association of erythromycin A and azithromycin with liposomes of phosphatidylglycerol containing unsaturated fatty acid(s) J. Microencapsulation 8 1991 171 183
24. W.Q. Sun, A.C. Leopold, L.M. Crowe, and J.H. Crowe Stability of dry liposomes in sugar glasses Biophys. J. 70 1996 1769 1776
25. H. Vorbach, G. Weigel, B. Robibaro, C. Armbruster, R. Schaumann, M. Hlousek, M. Reiter, A. Griesmacher, and A. Georgopoulos Endothelial cell compatibility of clarithromycin for intravenous use Clin. Biochem. 31 1998 653 656
26. Y. Wang, G.M. Mesfin, C.A. Rodriguez, J.G. Slatter, M.R. Schuette, A.L. Cory, and M.J. Higgins Venous irritation, pharmacokinetics, and tissue distribution of tirilazad in rats following intravenous administration of a novel supersaturated submicron lipid emulsion Pharm. Res. 16 1999 930 938
27. W. Weibull A statistical distribution function of wide applicability J. Appl. Mech. 18 1951 293 297
28. F. Zakir, B. Vaidya, A.K. Goyal, B. Malik, and S.P. Vyas Development and characterization of oleic acid vesicles for the topical delivery of fluconazole Drug Deliv. 17 2010 238 248
29. T. Zimmermann, H. Laufen, K.D. Riedel, G. Treadway, and A. Wildfeuer Comparative tolerability of intravenous azithromycin, clarithromycin and erythromycin in healthy volunteers: results of a double-blind, double-dummy, four-way crossover study Clin. Drug Investig. 21 2001 527 536